LU78775A1 - - Google Patents

Info

Publication number
LU78775A1
LU78775A1 LU78775A LU78775A LU78775A1 LU 78775 A1 LU78775 A1 LU 78775A1 LU 78775 A LU78775 A LU 78775A LU 78775 A LU78775 A LU 78775A LU 78775 A1 LU78775 A1 LU 78775A1
Authority
LU
Luxembourg
Application number
LU78775A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU78775A1 publication Critical patent/LU78775A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LU78775A 1977-01-25 1977-12-28 LU78775A1 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2872/77A GB1557082A (en) 1977-01-25 1977-01-25 Pharmaceutical mixture containing an antiinflammatory

Publications (1)

Publication Number Publication Date
LU78775A1 true LU78775A1 (en:Method) 1978-07-11

Family

ID=9747602

Family Applications (1)

Application Number Title Priority Date Filing Date
LU78775A LU78775A1 (en:Method) 1977-01-25 1977-12-28

Country Status (16)

Country Link
US (2) US4151292A (en:Method)
JP (1) JPS5394038A (en:Method)
AU (1) AU522148B2 (en:Method)
BE (1) BE862310A (en:Method)
CA (1) CA1099641A (en:Method)
CH (1) CH629960A5 (en:Method)
DE (1) DE2756802A1 (en:Method)
DK (1) DK576077A (en:Method)
FI (1) FI773882A7 (en:Method)
FR (1) FR2377804A1 (en:Method)
GB (1) GB1557082A (en:Method)
IL (1) IL53693A (en:Method)
LU (1) LU78775A1 (en:Method)
NL (1) NL7800016A (en:Method)
NO (1) NO774400L (en:Method)
SE (1) SE7714692L (en:Method)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1595220A (en) * 1977-12-23 1981-08-12 Fisons Ltd Tablets containing 1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane
HU185926B (en) * 1979-09-27 1985-04-28 Agostne Kahan Process for preparing water soluble derivatives of non-steroid antiinflammatory compositions and pharmaceutical compositins containing such derivatives
BG39424A1 (en) * 1984-03-09 1986-06-16 Iliev Method for dynamic balancing in mounted state of rotary machines symetric with regard to gravity centre
FR2613619B1 (fr) * 1987-04-07 1993-10-15 Recherche Informatique Pharmacie Medicaments, produits dietetiques ou produits d'hygiene sous forme de compositions pulverulentes obtenues par adsorption de principes actifs sur un sucre a dissolution rapide
US4743596A (en) * 1987-06-16 1988-05-10 Lapin Alfred R Anti-arthritic preparation
GB9824604D0 (en) * 1998-11-11 1999-01-06 Hewlett Healthcare Limited Treatment of allergic conditions
TWI241195B (en) * 2000-04-10 2005-10-11 Shionogi & Co Preventive agent for bile acidic diarrhea
TWI504419B (zh) * 2006-11-09 2015-10-21 Orexigen Therapeutics Inc 層狀醫藥調配物
US20080306506A1 (en) * 2007-06-11 2008-12-11 Leatherman Dennis A Self-inflating and deflating intragastric balloon implant device

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1144905A (en) * 1965-03-25 1969-03-12 Fisons Pharmaceuticals Ltd Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
GB1557082A (en) 1979-12-05
IL53693A0 (en) 1978-03-10
BE862310A (fr) 1978-06-23
NL7800016A (nl) 1978-07-27
AU3193977A (en) 1979-06-28
CH629960A5 (fr) 1982-05-28
SE7714692L (sv) 1978-07-26
DK576077A (da) 1978-07-26
US4232012A (en) 1980-11-04
US4151292A (en) 1979-04-24
JPS5394038A (en) 1978-08-17
FR2377804B1 (en:Method) 1980-10-31
IL53693A (en) 1981-09-13
FR2377804A1 (fr) 1978-08-18
DE2756802A1 (de) 1978-07-27
AU522148B2 (en) 1982-05-20
NO774400L (no) 1978-07-26
FI773882A7 (fi) 1978-07-26
CA1099641A (en) 1981-04-21

Similar Documents

Publication Publication Date Title
DE2858268A1 (en:Method)
FR2377230B1 (en:Method)
FR2376868B1 (en:Method)
FR2377400B2 (en:Method)
FR2378978B1 (en:Method)
FR2376996B1 (en:Method)
FR2377804B1 (en:Method)
FR2376793B2 (en:Method)
FR2377107B3 (en:Method)
AU3353778A (en:Method)
FR2378829B1 (en:Method)
FR2376642B1 (en:Method)
FR2377494B2 (en:Method)
DK140070C (en:Method)
FR2377848B3 (en:Method)
AR210643A1 (en:Method)
AU495917B2 (en:Method)
AU71461S (en:Method)
BE865722A (en:Method)
BG25855A1 (en:Method)
BE851449A (en:Method)
BG25837A1 (en:Method)
BE866391A (en:Method)
BE868323A (en:Method)
BE870787A (en:Method)